title: Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
authors.affiliation: National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK silvia.rabar@rcplondon.ac.uk.
authors.forename: Silvia
authors.initials: S
authors.lastname: Rabar
authors.affiliation: National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
authors.forename: Martin
authors.initials: M
authors.lastname: Harker
authors.affiliation: National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
authors.forename: Norma
authors.initials: N
authors.lastname: O'Flynn
authors.affiliation: Guy's and St Thomas' Hospitals, London, UK.
authors.forename: Anthony S
authors.initials: AS
authors.lastname: Wierzbicki
mesh_terms: D000837:Anion Exchange Resins / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D048909:Diabetes Complications; D004032:Diet; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D058607:Fibric Acids / Q000008:administration & dosage; D005919:Glomerular Filtration Rate; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D008055:Lipids / Q000097:blood*; D009539:Nicotinic Acids / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D051436:Renal Insufficiency, Chronic / Q000150:complications; D018570:Risk Assessment; D055502:Secondary Prevention
chemical_list: D000837:Anion Exchange Resins; D015525:Fatty Acids, Omega-3; D058607:Fibric Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D009539:Nicotinic Acids